GRAS Loophole Allows Thousands of Untested Food Additives in US
The 1958 Food Additives Amendment to the Federal Food, Drug, and Cosmetic Act created two pathways: one requiring FDA safety review for new additives, and a 'generally recognized as safe' (GRAS) exemption for common ingredients like vinegar. However, the GRAS pathway has been exploited by food companies to introduce thousands of industrially produced chemicals without FDA notification or public disclosure. Companies self-determine GRAS status using unpublished studies and industry-paid expert panels. The Trump administration, via Health Secretary Robert F. Kennedy Jr., directed the FDA in March to explore closing this loophole. NYU professor Jennifer Pomeranz notes that the FDA has been historically slow to act, citing the 30-year struggle to remove partially hydrogenated vegetable oil (trans fat), which was not fully banned until 2023. The Consumer Brands Association defends industry practices, claiming strict safety protocols. Pomeranz emphasizes that even if new rules require pre-market notification, ingredients already in the supply chain remain unaddressed, and FDA funding for review is uncertain. User fees, similar to those paid by pharmaceutical companies, have been proposed to fund the process.
Key facts
- The 1958 Food Additives Amendment created a GRAS exemption for common ingredients.
- Food companies can self-determine GRAS status without notifying the FDA.
- Thousands of new ingredients are in the food supply unknown to the FDA.
- Industry GRAS panels are 100% composed of experts with conflicts of interest.
- Partially hydrogenated vegetable oil took over 30 years to be banned by the FDA.
- The FDA did not fully ban trans fat until 2023.
- Health Secretary RFK Jr. directed the FDA in March 2026 to explore closing the GRAS loophole.
- User fees have been proposed to fund FDA review of new ingredients.
Entities
Institutions
- Food and Drug Administration (FDA)
- NYU School of Global Public Health
- Consumer Brands Association
- Government Accountability Office
- Institute of Medicine (National Academy of Medicine)
- Office of Management and Budget
- Department of Health and Human Services
Locations
- United States
- Italy
- Europe
- Canada